• 1. Stereodynamics of ring and nitrogen inversion in spiroheterocycles. Conformational analysis of N-methylspiro[morpholine-3,2′-adamantane] and N-methylspiro[piperidine-2,2′-adamantane] using NMR spectroscopy and theoretical calculations
  Antonios Kolocouris,Emmanuel Mikros,Nicolas Kolocouris J. Chem. Soc. Perkin Trans. 2 1998 1701

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Oxazinanes Morpholines

Recent Advances in the Application of 3,3-Dimethylmorpholine (CAS: 59229-63-9) in Chemical Biology and Pharmaceutical Research

3,3-Dimethylmorpholine (CAS: 59229-63-9) is a versatile heterocyclic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its morpholine core with two methyl substituents at the 3-position, has been explored for its role as a building block in drug discovery, catalysis, and material science. Recent studies have highlighted its utility in the synthesis of bioactive molecules, particularly in the development of kinase inhibitors and antimicrobial agents.

One of the key areas of research involving 3,3-Dimethylmorpholine is its incorporation into small-molecule inhibitors targeting protein kinases. Kinases play a critical role in cellular signaling pathways, and their dysregulation is associated with various diseases, including cancer and inflammatory disorders. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 3,3-Dimethylmorpholine as a scaffold for designing selective inhibitors of the PI3K/AKT/mTOR pathway, which is frequently aberrant in cancer. The study reported that derivatives of 3,3-Dimethylmorpholine exhibited improved pharmacokinetic properties and reduced off-target effects compared to earlier generations of inhibitors.

In addition to its role in kinase inhibition, 3,3-Dimethylmorpholine has been investigated for its antimicrobial properties. A recent publication in Bioorganic & Medicinal Chemistry Letters described the synthesis of novel morpholine derivatives, including 3,3-Dimethylmorpholine, and their evaluation against multidrug-resistant bacterial strains. The results indicated that certain derivatives exhibited potent activity against Gram-positive bacteria, with minimal cytotoxicity to mammalian cells. These findings suggest that 3,3-Dimethylmorpholine could serve as a promising lead compound for the development of new antibiotics.

Another emerging application of 3,3-Dimethylmorpholine is in the field of asymmetric catalysis. Researchers have explored its use as a chiral auxiliary or ligand in catalytic reactions, enabling the enantioselective synthesis of complex molecules. A 2022 study in ACS Catalysis reported the successful employment of a 3,3-Dimethylmorpholine-derived ligand in the asymmetric hydrogenation of ketones, achieving high enantiomeric excess and yield. This advancement opens new avenues for the synthesis of chiral pharmaceuticals and fine chemicals.

Despite these promising developments, challenges remain in the optimization of 3,3-Dimethylmorpholine-based compounds for clinical use. Issues such as metabolic stability, solubility, and selectivity need to be addressed through further structural modifications and preclinical studies. Ongoing research is focused on leveraging computational chemistry and structure-activity relationship (SAR) studies to refine the properties of these molecules.

In conclusion, 3,3-Dimethylmorpholine (CAS: 59229-63-9) represents a valuable scaffold in chemical biology and pharmaceutical research, with demonstrated potential in kinase inhibition, antimicrobial therapy, and asymmetric catalysis. Continued exploration of its derivatives and applications is expected to yield novel therapeutic agents and catalytic tools, contributing to advancements in medicine and chemical synthesis.

• 1195593-67-9(3,3,5-Trimethylmorpholine)
• 87787-69-7(ETHANOL, 2-[2-[(1,1-DIMETHYLETHYL)AMINO]PROPOXY]-)
• 93565-31-2(1,4,7,10-Tetraoxa-13-azacyclopentadecane, 12,12,14,14-tetramethyl-)
• 90017-25-7(2-Propanamine, 1-methoxy-N-(2-methoxy-1,1-dimethylethyl)-2-methyl-)
• 59229-64-0(3,3-Dimethylmorpholine hydrochloride)
• 858197-58-7(2-methyl-2-(morpholin-4-yl)propan-1-ol)
• 1240725-47-6(2,8-Dioxa-5-azaspiro[3.5]nonane)
• 1175761-30-4((S)-3,3,5-Trimethylmorpholine)
• 111722-45-3(3,3-Morpholinedimethanol, 4-methyl-)
• 19412-12-5(3,3,5,5-Tetramethylmorpholine Hydrochloride)